Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

American Journal of Medicine

Volumn 123, Issue 5, 2010, Pages 446-453

  Zimetbaum, Peter J ^a   Thosani, Amit ^a   Yu, Hsing Ting ^b   Xiong, Yan ^b   Lin, Jay ^c   Kothawala, Prajesh ^b   Emons, Matthew ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CERNER CORPORATION   (United States)

^c SANOFI   (France)

Author keywords

Anticoagulation; Atrial fibrillation; Atrial flutter; Stroke risk; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STROKE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; WARFARIN;

EID: 77950649308     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.11.015     Document Type: Article

References (35)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375
2. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998) 946-952
3. Wolf P.A., Mitchell J.B., Baker C.S., et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158 (1998) 229-234
4. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22 (1991) 983-988
5. Coyne K.S., Paramore C., Grandy S., et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 9 (2006) 348-356
6. Biblo L.A., Yuan Z., Quan K.J., et al. Risk of stroke in patients with atrial flutter. Am J Cardiol 87 (2001) 346-349 A349
7. Dulli D.A., Stanko H., and Levine R.L. Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 22 (2003) 118-123
8. Lip G.Y. Does atrial fibrillation confer a hypercoagulable state?. Lancet 346 (1995) 1313-1314
9. Chung N.A., Belgore F., Li-Saw-Hee F.L., et al. Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?. Stroke 33 (2002) 2187-2191
10. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
11. Connolly S.J. ATHENA: The effect of dronedarone on cardiovascular outcomes and stroke in patients with atrial fibrillation. Program and abstracts from the European Society of Cardiology Congress 2008 (2008), Munich, Germany Clinical trials update 3
12. Van Gelder I.C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
13. Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
14. Carlsson J., Miketic S., Windeler J., et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41 (2003) 1690-1696
15. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
16. Hart R.G., Benavente O., McBride R., and Pearce L.A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131 (1999) 492-501
17. Singer D.E., Albers G.W., Dalen J.E., et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6 Suppl (2008) 546S-592S
18. van Walraven C., Hart R.G., Wells G.A., et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 163 (2003) 936-943
19. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
20. Hughes M., and Lip G.Y. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 99 (2008) 295-304
21. Lewis W.R., Fonarow G.C., LaBresh K.A., et al. Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. Am J Cardiol 103 (2009) 227-231
22. Fang M.C., Stafford R.S., Ruskin J.N., and Singer D.E. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 164 (2004) 55-60
23. Nieuwlaat R., Capucci A., Lip G.Y., et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 27 (2006) 3018-3026
24. Gladstone D.J., Bui E., Fang J., et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40 (2009) 235-240
25. Waldo A.L., Becker R.C., Tapson V.F., and Colgan K.J. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46 (2005) 1729-1736
26. Meiltz A., Zimmermann M., Urban P., and Bloch A. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 10 (2008) 674-680
27. Goldman H.H., Frank R.G., Burnam M.A., et al. Behavioral health insurance parity for federal employees. N Engl J Med 354 (2006) 1378-1386
28. Chernew M., Gibson T.B., Yu-Isenberg K., et al. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med 23 (2008) 1131-1136
29. Mark T.L., Axelsen K.J., Mucha L., and Sadkova Y. Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients. Am J Manag Care 13 Suppl 3 (2007) S72-S79
30. Romano P.S., Roos L.L., and Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 46 (1993) 1075-1079 discussion 1081-1090
31. Hylek E.M., Evans-Molina C., Shea C., et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115 (2007) 2689-2696
32. DiMarco J.P., Flaker G., Waldo A.L., et al. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149 (2005) 650-656
33. Hughes M., and Lip G.Y. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM 100 (2007) 599-607
34. Hohnloser S.H., Pajitnev D., Pogue J., et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 50 (2007) 2156-2161
35. Crystal E., and Connolly S.J. Role of oral anticoagulation in management of atrial fibrillation. Heart 90 (2004) 813-817